Trainees participating in the T32 Research Training Program in Cardiovascular Research and Drug Development will perform mentored research in their faculty preceptor’s lab. In addition, they will ...
This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Life sciences is among the most ...
Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries including Bristol-Myers Squibb, Celgene Corporation, Aurinia Pharmaceuticals, Abbvie, Nanomedicine Innovation Center.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback